scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH), a company dedicated to innovative healthcare solutions, announced its CEO John Tucker will present at the H.C. Wainwright Global Investment Conference on May 24, 2022, at 3:00 PM EDT in Miami, FL. The conference aims to highlight advancements in outpatient care and healthcare cost reduction. A live webcast of the presentation will be available on the company's Investor Relations webpage. scPharmaceuticals specializes in developing products for outpatient care, focusing on IV-strength treatments for heart failure and infectious diseases.

BURLINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24 at 3:00pm EDT, at the Fontainebleau Miami Beach Hotel in Miami, FL.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com 

FAQ

When is SCPH presenting at the H.C. Wainwright Global Investment Conference?

scPharmaceuticals Inc. will present on May 24, 2022, at 3:00 PM EDT.

Where is the H.C. Wainwright Global Investment Conference held?

The conference will be held at the Fontainebleau Miami Beach Hotel in Miami, FL.

How can I watch the SCPH presentation live?

The live presentation can be accessed via the 'News & Events' section on scPharmaceuticals' Investor Relations webpage.

What is the focus of scPharmaceuticals' development?

scPharmaceuticals develops products aimed at reducing healthcare costs and improving health outcomes, particularly for outpatient care in heart failure and infectious diseases.